Franklin Resources’s Avadel Pharmaceuticals AVDL Stock Holding History

Franklin Resources’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-58,821	Closed	-$1.27M	–	3160
2025 Q4	$1.27M	Buy	58,821 +2,465	+4%	+$47.9K	﹤0.01%	1982
2025 Q3	$861K	Buy	56,356 +36,650	+186%	+$477K	﹤0.01%	2186
2025 Q2	$174K	Buy	+19,706	New	+$173K	﹤0.01%	2782

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Franklin Resources's AVDL Position: Q1 2026 in Review

Franklin Resources sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 58,821 shares — an estimated $1.27M sold.

Franklin Resources first reported a position in AVDL in Q2 2025 and held it in 3 quarters. The position peaked at $1.27M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Franklin Resources reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Franklin Resources sold 58,821 Avadel Pharmaceuticals shares in Q1 2026, an estimated $1.27M.
Franklin Resources first reported a position in Avadel Pharmaceuticals in Q2 2025 and held it in 3 quarters.
Franklin Resources's Avadel Pharmaceuticals position peaked at $1.27M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.